SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is experiencing significant volatility, driven by discussions of a potential short squeeze and low float mania. Community members are actively debating the stock's fundamentals, potential for further gains, and comparisons to other high-flying low floaters like SNSE. Caution is advised, as some users are calling SMX a "scam" and pointing to a history of reverse splits.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SOFI is trending due to a recent announcement of a $1.5 billion public stock offering, leading to concerns about shareholder dilution. The community is debating the strategic implications of this move, especially its potential impact on the company's chances of S&P 500 inclusion. Some believe the offering is a strategic move for growth, while others express frustration over perceived short-term pain for long-term gain.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as community members discuss its potential breakout against Bitcoin and Ethereum, highlighting upcoming technical formations. There is also speculation around possible ETF developments, with some users pointing out Litecoin's long-term stability and real-world payment utility. Community is also discussing Litecoin's halving event in 2027 and litvm in 2028.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

Q/C Technologies Inc. ($QCLS) is trending after American pharma investor Martin Shkreli announced taking a position, citing the company's potential in photonic computing over quantum. The community is actively discussing price targets and comparing it to other recent low-float runners like $SMX, anticipating a potential short squeeze. Bullish sentiment is building around Shkreli's involvement and the company's technology.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics ($SNSE) is trending due to a significant overnight surge, sparking discussions of a potential short squeeze and comparisons to other high-flying stocks like $SMX. Community members are actively debating the reasons behind the pump and whether it can be sustained, with some pointing to the stock's small float and coordinated social media attention. Others are expressing caution, citing the company's fundamentals and potential for a pullback.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo ($OKLO) is trending as investors discuss the implications of a recently announced $1.5B stock offering and a new partnership, with community debates focusing on whether these moves signal long-term growth or potential dilution. Community members are also weighing the company's prospects against others in the sector. Sentiment is mixed, with some highlighting institutional ownership and potential for future buildouts, while others express concerns about the company's revenue and business model.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

CAPR is trending due to positive Phase 3 trial results for its DMD treatment, sparking optimism about FDA approval and potential market dominance. The community is debating the likelihood of a near-term offering and its impact, while also comparing CAPR's prospects to other biotech companies like ABVX. Discussions also involve potential buyout scenarios and the value of its exosome platform.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik is trending as investors assess its long-term potential in cybersecurity, particularly its role in ransomware protection and data resilience, with some highlighting strong growth metrics and recurring revenue. The community is weighing the impact of new AI operations and potential for market consolidation, driven by strong earnings reports that have caused the stock to soar. Discussions also involve the company's unique positioning, particularly in relation to the increasing need for data protection amid rising cyber threats.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending as community members debate its volatile price action and potential for a short squeeze, while some express skepticism about its long-term prospects and compare it to other speculative stocks. Discussions also revolve around potential offerings, insider selling, and technical analysis, contributing to the stock's current buzz. Within the quantum computing sector, chatter is about potential breakout and the influence of new ETFs.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending as the community discusses the potential for a buyout or strategic partnership, particularly given promising data in lung, prostate, and pancreatic cancers. Discussions highlight the company's perceived undervaluation and substantial short interest, suggesting a possible short squeeze. Some are pointing to a potential shift in FDA approval processes that could benefit CADL.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

I did research on $HLN, a biotech stock currently in oversold territory. It is a sister company of GSK, demerged from GSK in 2022. I see it as a long-term hold with potential gains. It has several buy ratings and runs a profitable pharma business. Obviously, it is backed by GSK. 
 
The only downside risk is litigation related to the Zantac drug, which is still in court. HLN was one of many manufacturers of the OTC version for gas relief, but they clarified in a press release that they have no involvement. Other than that, there is no publicly available negative news.

StocksNcryptoP

StockTwits Web

HALEON PLC SPON ADS EACH REP 2 ORD SHS WI

, a biotech stock currently in oversold territory. It is a sister company of GSK, demerged from GSK in 2022. I see it as a long-term hold with potential gains. It has several buy ratings and runs a profitable pharma business. Obviously, it is backed by GSK. 
 
The only downside risk is litigation related to the Zantac drug, which is still in court. HLN was one of many manufacturers of the OTC version for gas relief, but they clarified in a press release that they have no involvement. Other than that, there is no publicly available negative news.